Suresh Senan

Research interests

Publications

• Four-Year Survival With Durvalumab After Chemoradiotherapy in Stage III NSCLC—an Update From the PACIFIC Trial

  Journal of Thoracic Oncology · 2021 · https://doi.org/10.1016/j.jtho.2020.12.015

• Practice recommendations for lung cancer radiotherapy during the COVID-19 pandemic: An ESTRO-ASTRO consensus statement

  Radiotherapy and Oncology · 2020 · https://doi.org/10.1016/j.radonc.2020.04.001

• Stereotactic Ablative Radiotherapy for the Comprehensive Treatment of Oligometastatic Cancers: Long-Term Results of the SABR-COMET Phase II Randomized Trial

  Journal of Clinical Oncology · 2020 · https://doi.org/10.1200/jco.20.00818

• Managing cancer patients during the COVID-19 pandemic: an ESMO multidisciplinary expert consensus

  Annals of Oncology · 2020 · https://doi.org/10.1016/j.annonc.2020.07.010

• Radiation-induced lung toxicity – cellular and molecular mechanisms of pathogenesis, management, and literature review

  Radiation Oncology · 2020 · https://doi.org/10.1186/s13014-020-01654-9

• Stereotactic ablative radiotherapy versus standard of care palliative treatment in patients with oligometastatic cancers (SABR-COMET): a randomised, phase 2, open-label trial

  The Lancet · 2019 · https://doi.org/10.1016/s0140-6736(18)32487-5

• ESTRO ACROP consensus guideline on implementation and practice of stereotactic body radiotherapy for peripherally located early stage non-small cell lung cancer

  Radiotherapy and Oncology · 2017 · https://doi.org/10.1016/j.radonc.2017.05.012

• Early and locally advanced non-small-cell lung cancer (NSCLC): ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up

  Annals of Oncology · 2017 · https://doi.org/10.1093/annonc/mdx222

• Metastatic non-small-cell lung cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up

  Annals of Oncology · 2016 · https://doi.org/10.1093/annonc/mdw326

• PROCLAIM: Randomized Phase III Trial of Pemetrexed-Cisplatin or Etoposide-Cisplatin Plus Thoracic Radiation Therapy Followed by Consolidation Chemotherapy in Locally Advanced Nonsquamous Non–Small-Cell Lung Cancer

  Journal of Clinical Oncology · 2016 · https://doi.org/10.1200/jco.2015.64.8824

• Stereotactic ablative radiotherapy versus lobectomy for operable stage I non-small-cell lung cancer: a pooled analysis of two randomised trials

  The Lancet Oncology · 2015 · https://doi.org/10.1016/s1470-2045(15)70168-3

• Use of thoracic radiotherapy for extensive stage small-cell lung cancer: a phase 3 randomised controlled trial

  The Lancet · 2014 · https://doi.org/10.1016/s0140-6736(14)61085-0

• An Individual Patient Data Metaanalysis of Outcomes and Prognostic Factors After Treatment of Oligometastatic Non–Small-Cell Lung Cancer

  Clinical Lung Cancer · 2014 · https://doi.org/10.1016/j.cllc.2014.04.003

• 2nd ESMO Consensus Conference on Lung Cancer: early-stage non-small-cell lung cancer consensus on diagnosis, treatment and follow-up

  Annals of Oncology · 2014 · https://doi.org/10.1093/annonc/mdu089

• 2nd ESMO Consensus Conference on Lung Cancer: early-stage non-small-cell lung cancer consensus on diagnosis, treatment and follow-up

  Annals of Oncology · 2014 · https://doi.org/10.1093/annonc/mdu089

• Predicting Radiation Pneumonitis After Chemoradiation Therapy for Lung Cancer: An International Individual Patient Data Meta-analysis

  International Journal of Radiation Oncology*Biology*Physics · 2013 · https://doi.org/10.1016/j.ijrobp.2012.04.043

• Patterns of disease recurrence after stereotactic ablative radiotherapy for early stage non-small-cell lung cancer: a retrospective analysis

  The Lancet Oncology · 2012 · https://doi.org/10.1016/s1470-2045(12)70242-5

• Extra-pleural pneumonectomy versus no extra-pleural pneumonectomy for patients with malignant pleural mesothelioma: clinical outcomes of the Mesothelioma and Radical Surgery (MARS) randomised feasibility study

  The Lancet Oncology · 2011 · https://doi.org/10.1016/s1470-2045(11)70149-8

• Outcomes of Stereotactic Ablative Radiotherapy in Patients With Potentially Operable Stage I Non-Small Cell Lung Cancer

  International Journal of Radiation Oncology*Biology*Physics · 2011 · https://doi.org/10.1016/j.ijrobp.2011.06.2003

• European Organisation for Research and Treatment of Cancer Recommendations for Planning and Delivery of High-Dose, High-Precision Radiotherapy for Lung Cancer

  Journal of Clinical Oncology · 2010 · https://doi.org/10.1200/jco.2010.30.3271

• Consideration of Dose Limits for Organs at Risk of Thoracic Radiotherapy: Atlas for Lung, Proximal Bronchial Tree, Esophagus, Spinal Cord, Ribs, and Brachial Plexus

  International Journal of Radiation Oncology*Biology*Physics · 2010 · https://doi.org/10.1016/j.ijrobp.2010.07.1977

• Impact of Introducing Stereotactic Lung Radiotherapy for Elderly Patients With Stage I Non–Small-Cell Lung Cancer: A Population-Based Time-Trend Analysis

  Journal of Clinical Oncology · 2010 · https://doi.org/10.1200/jco.2010.30.0731

• Volumetric Intensity-Modulated Arc Therapy Vs. Conventional IMRT in Head-and-Neck Cancer: A Comparative Planning and Dosimetric Study

  International Journal of Radiation Oncology*Biology*Physics · 2009 · https://doi.org/10.1016/j.ijrobp.2008.12.033

• Standard-dose versus higher-dose prophylactic cranial irradiation (PCI) in patients with limited-stage small-cell lung cancer in complete remission after chemotherapy and thoracic radiotherapy (PCI 99-01, EORTC 22003-08004, RTOG 0212, and IFCT 99-01): a randomised clinical trial

  The Lancet Oncology · 2009 · https://doi.org/10.1016/s1470-2045(09)70101-9

• Outcomes of Risk-Adapted Fractionated Stereotactic Radiotherapy for Stage I Non–Small-Cell Lung Cancer

  International Journal of Radiation Oncology*Biology*Physics · 2008 · https://doi.org/10.1016/j.ijrobp.2007.10.053

• Prophylactic Cranial Irradiation in Extensive Small-Cell Lung Cancer

  New England Journal of Medicine · 2007 · https://doi.org/10.1056/nejmoa071780

Current projects

No projects listed.